-
Abstract Number: PB0925
p.G2752S Severely Affects Dimerization of von Willebrand Factor: An Analysis of Type 3 von Willebrand Disease
-
Abstract Number: PB0876
P2Y12 Receptor Antagonists and Drug-induced Thrombotic Microangiopathies: A Systematic Review of the Primary Evidence
-
Abstract Number: PB0427
P2Y12 Inhibitors Administration in Intracranial Stent Procedure, the Usefulness of Monitoring
-
Abstract Number: OC 51.2
Paediatric D-dimer and Fibrin Degradation Products (FDP) Reference Intervals Using STA® Liatest D-Di Plus and STA® Liatest FDP
-
Abstract Number: PB0912
Palmitate Increases Gene Expression and Stimulated Secretion of von Willebrand Factor in Human Umbilical Vein Endothelial Cells
-
Abstract Number: PB1136
Pancreatic-miRaCan-VTE: A R Shiny App to Aid in the Diagnosis of Pancreatic Cancer-associated VTE
-
Abstract Number: PB1002
Pandrial Platelet Reactivity in Aspirin-treated Individuals: A Comparison between Fasting and Non Fasting On-treatment Platelet Responses
-
Abstract Number: PB1010
Pathogen-reduced Platelet Concentrates: Novel Concepts to Elucidate the Impact of Different Technologies on Platelet Function
-
Abstract Number: PB1152
Pathologically Stiff Erythrocytes Can Promote Thrombosis by Impeding Contraction of Blood Clots
-
Abstract Number: PB0619
Patient and Healthcare Professional Perspectives on the Use of a Personal Health Record in Hemophilia Care: A Qualitative Study
-
Abstract Number: PB1265
Patient Satisfaction with Quality of Care from a New Multidisciplinary Thrombosis Service
-
Abstract Number: PB0641
Patient-centered Digital Health Interventions and their Effects on Health Outcomes: A Systematic Review
-
Abstract Number: PB0932
Patient-reported Outcomes in Autosomal Inherited Bleeding Disorders: A Systematic Literature Review
-
Abstract Number: PB0584
Patients with Hemophilia B with Inhibitors in China
-
Abstract Number: PB0573
Patients with Severe Hemophilia A under Middle-dosed Prophylaxis Benefit from Multi-disciplinary Team Management, an Experience
-
Abstract Number: OC 19.2
Patients with VEXAS Syndrome due to Somatic Mutations in UBA1 Present Commonly with Thrombosis
-
Abstract Number: OC 69.4
Pediatric Leukemic Lymphoblasts Produce Hemostatic System Factors: A Novel Contributor to the Hemostatic Imbalance in Pediatric Acute Lymphoblastic Leukemia
-
Abstract Number: PB0799
Pediatric Thromboembolism in Chiang Mai University Hospital: A 10-year Review
-
Abstract Number: PB0068
Performance Evaluation of a New VWF:GPIbM VWF Activity Assay in a Multicenter Study
-
Abstract Number: PB0071
Performance Evaluation of the INNOVANCE Anti-Xa Assay for the Quantitative Determination of Apixaban
-
Abstract Number: PB0064
Performance Evaluation of the INNOVANCE Anti-Xa Assay for the Quantitative Determination of Rivaroxaban
-
Abstract Number: OC 08.3
Peri-operative PK-guided Dosing of Desmopressin Combined with FVIII Concentrates in Hemophilia A: Final Results of the DAVID Study
-
Abstract Number: OC 46.1
Peri-procedural Heparin Use in Patients Receiving Edoxaban: Analyses of the Noninterventional Global EMIT (Edoxaban Management in Diagnostic and Therapeutic Procedures) Study
-
Abstract Number: PB0109
Peridontal Injury Prompts Remote Spleen Activation and the Generation of Spleen Procoagulant Microvesicles in a Periodontitis Murine Model
-
Abstract Number: PB1310
Perinatal Outcome of Normal Pregnant and Pregnant Women Hospitalized for Hypertension (PIH: Pregnancy Induced Hypertension) and Studied for Antiphospholipid Antibodies (aPL) at Time of PIH Onset
-
Abstract Number: PB0941
Perioperative Management of Patients with von Willebrand Disease Undergoing Surgical Interventions
-
Abstract Number: LPB0003
Persistence Pattern to Oral Anticoagulants among Non-valvular Atrial Fibrillation Patients who Switched from Vitamin K Antagonists to Direct Oral Anticoagulants: A Cohort Study
-
Abstract Number: PB0089
Persistently Low Levels of Antithrombin in Trauma Patients Associated with Disseminated Intravascular Coagulation
-
Abstract Number: OC 23.1
Personalized Cancer-associated Thrombosis Risk Assessment: Integration of Plasma Proteomics, Clinical Characteristics, and Machine Learning
-
Abstract Number: PB0859
PF4/Polyanion ELISA-negative Antibodies to PF4 and Non-PF4 Targets Can Mediate Platelet Activation and Cause Heparin-induced Thrombocytopenia (HIT)
-
Abstract Number: OC 17.4
Pharmacodynamics of Bolus with and without Infusion of Cangrelor in Healthy Volunteers: A Dose-finding, Open-label, Pilot Trial
-
Abstract Number: OC 24.3
Pharmacokinetic Analysis of fVIII Exposure Identifies an Immunogenicity Threshold after AAV-FVIII Gene Therapy in a Murine Hemophilia A Model
-
Abstract Number: PB0568
Pharmacokinetic-guided Prophylaxis Improved Clinical Outcomes in 46 Pediatric Patients with Severe Hemophilia A
-
Abstract Number: PB0077
Pharmacokinetics and Pharmacodynamics of Abelacimab (MAA868), a Novel Dual Inhibitor of Factor XI and Factor XIa
-
Abstract Number: PB0614
Pharmacokinetics-adjusted Dosing of Rurioctocog Alfa Pegol (Adynovi) in Adult Patients with Haemophilia A
-
Abstract Number: PB0917
Pharmacokinetics/Pharmacodynamics (PK/PD) of Recombinant von Willebrand Factor (Vonicog Alfa) in Adult Patients with von Willebrand Disease (VWD) during Prophylactic Treatment
-
Abstract Number: PB1224
Pharmacologic Profiles of Direct Oral Anticoagulants in Patients Receiving Rituximab-CHOP Chemotherapy
-
Abstract Number: PB0958
Pharmacological Characterization of eNOS-based Megakaryocyte Subpopulations and its Implications for their Platelet Progeny
-
Abstract Number: OC 71.1
Pharmacological Targeting of Coagulation Factor XI Mitigates the Development of Experimental Atherosclerosis in Low-density Lipoprotein Receptor-deficient Mice
-
Abstract Number: PO174
Pharmacological Venous Thromboembolism Prophylaxis in an Internal Medicine Ward: Cross-sectional Observational Study
-
Abstract Number: LPB0128
Phase 3 Trial Results: Prophylaxis with Recombinant von Willebrand Factor in Patients with Severe von Willebrand Disease
-
Abstract Number: OC 72.2
Phase I/II Ongoing Study of Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Immune Thrombocytopenia: Extended Follow-up and Long-term Analyses with Optimal Dose
-
Abstract Number: OC 67.2
Phase I/II Trial of SPK-8011: Stable and Durable FVIII Expression After AAV Gene Transfer for Hemophilia A
-
Abstract Number: PB0700
Phenotype-Genotype Relationship in Patients with Hereditary FXI Deficiency
-
Abstract Number: PB0761
Phenotypic Changes in Platelets during Measles Virus Infection of Rhesus Macaques (Macaca Mulatta)
-
Abstract Number: PB0023
Photodynamic Therapy with 5- Aminolevulinic Acid and B-mode Ultrasound-guided Catheter-based Low-level Red Laser Results in Cerebrovascular Neointimal Hyperplasia Regression
-
Abstract Number: PB0187
Physicians’ Knowledge and Management Practices of COVID-19 Coagulopathies in Pregnancy
-
Abstract Number: PB0987
PI4P and PI(4,5)P2 Immunofluorescence Staining Optimization in Human Platelets
-
Abstract Number: OC 09.1
Piggyback Knockdown Screen of Glycosyltransferases in Zebrafish: Identification of Novel Regulators of von Willebrand Factor Levels
-
Abstract Number: PB0851
PK/PD Modeling and Simulations Highlight the Importance of the Intravenous Loading Dose and Daily Dosing Regimen with Caplacizumab for Patients with aTTP
-
Abstract Number: PB0840
Plasma BioID of ADAMTS13
-
Abstract Number: PB1090
Plasma Biomarkers for Predicting Risk of Venous Thromboembolism (VTE) in Ambulatory Cancer Patients Receiving Chemotherapy
-
Abstract Number: PB0733
Plasma D-dimer and Fibrinogen Levels Correlates with Tumour Size and Disease Progression in Nigerian Breast Cancer Patients
-
Abstract Number: PB0939
Plasma-derived VWF/FVIII Concentrate (wilate®) for Haemostasis in Women with VWD during Childbirth
-
Abstract Number: PB0347
Plasmatic Rivaroxaban Concentration Estimation through the Measurement of Anti Xa Activity Calibrated with Heparin Calibrators Using 3 Reactive/Instrument Systems: Multicenter Study
-
Abstract Number: OC 26.4
Plasmin-responsive Procoagulant Synthetic Platelets for Fibrin Clot Stabilization in Hemorrhage Control
-
Abstract Number: OC 41.3
Plasminogen, but Not Fibrinogen, Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth and Metastasis
-
Abstract Number: PB1061
Plasmocytoid Dendritic Cells Activity in Asymptomatic Antiphospholipid Carriers and in Primary and Secondary Antiphospholipid Syndrome with Thrombosis
-
Abstract Number: PB0822
Platelet Activation and Function in Adult Patients with Primary Immune Thrombocytopenia
-
Abstract Number: LPB0141
Platelet Activation and Platelet Indices as Markers for Disease Progression in Women with Breast Cancer
-
Abstract Number: OC 70.4
Platelet Activation via PI3K/AKT Signaling Pathway in COVID-19
-
Abstract Number: PB0978
Platelet Activity and Platelet-induced Endothelial Inflammatory Pathways in Treated HIV Is Lowered by Clopidogrel: A Randomized Control Trial
-
Abstract Number: PB1060
Platelet Activity from Antiphospholipid Syndrome (APS) Patients is Enhanced: Possible Role of the ADP Signaling Pathway
-
Abstract Number: PB0817
Platelet Apoptosis and Autophagy in Pediatric Immune Thrombocytopenia: New Mechanistic Insights
-
Abstract Number: OC 11.2
Platelet Binding to Polymerizing Fibrin is Avidity-driven and Requires Activated αIIbβ3
-
Abstract Number: OC 52.3
Platelet Chemokines and Integrins Antagonistically Steer Neutrophil Activation in Arterial Thrombus Formation
-
Abstract Number: PB0208
Platelet Dynamics in Hospitalized Patients with SARS CoV-2 Infection
-
Abstract Number: PB0892
Platelet Dysfunction in Noonan Syndrome
-
Abstract Number: OC 15.1
Platelet Factor 4 (PF4) Enhances in vitro Neutrophil Extracellular Traps (NET) Capture of Coronaviruses: Clinical and Therapeutic Implications
-
Abstract Number: OC 40.3
Platelet Fibrinogen Receptor Expression and Platelet Function Decreases as Duration of ECMO Increases in Paediatric Veno-arterial ECMO Patients
-
Abstract Number: LPB0073
Platelet Function Is Inhibited by Dengue Virus
-
Abstract Number: PO160
Platelet Hyperaggregability and Migraine Headache – A Single Centre Experience
-
Abstract Number: PB0764
Platelet Involvement and its Association with Mortality in COVID-19 Patients at a Safety-net Hospital
-
Abstract Number: PB1048
Platelet microRNA Release in the Context of Agonist-stimulation and Thrombosis
-
Abstract Number: OC 41.1
Platelet microRNAs Inhibit Primary Tumor Growth via Broad Modulation of Tumor Cell mRNA Expression in Ectopic Pancreatic Cancer in Mice
-
Abstract Number: OC 10.3
Platelet Proteome and Variability in the Responsiveness to Low-dose Aspirin in Patients with Cardiovascular Disease
-
Abstract Number: OC 35.1
Platelet TFPIα Dampens Prothrombotic and Fibrotic Responses to Radiation Injury in Mouse Heart
-
Abstract Number: LPB0074
Platelet Transfusion Does Not Prevent Experimental Polymicrobial-induced Septic Shock in Mice
-
Abstract Number: PB0011
Platelet-derived Let-7e is an Independent Predictor of Long-term All-cause Mortality in Patients with Type 2 Diabetes Mellitus
-
Abstract Number: PB0021
Platelet-derived microRNAs Are Increased after Transcatheter Aortic Valve Implantation and May Predict Adverse Outcomes in Patients with Heart Failure
-
Abstract Number: LPB0135
Platelet-rich Neutrophil-platelet Micro-emboli Contribute to Cigarette Smoke-induced Influenza Severity
-
Abstract Number: LPB0129
Platelet-specific Deletion of Acetyl-CoA Carboxylase 1 Decreases Phospholipid Content and Impairs Platelet Functions
-
Abstract Number: PB0253
Platelets and Neutrophil Extracellular Traps (NETs) in Immunothrombosis Progression at COVID-19
-
Abstract Number: PB0319
Platelets Collected from Blood Diversion Pouches Are an Appropriate Alternative for Functional and Bioenergetic Analyses
-
Abstract Number: PB0201
Platelets from Donors of Convalescent Plasma after Mild COVID-19 Do Not Express Procoagulant Phenotype
-
Abstract Number: OC 31.3
Platelets from Patients with MYH9 Related Disorders Are Mechanically Stiffer
-
Abstract Number: PB0155
Platelets of COVID-19 Patients Are Refractory due to Thrombin Receptor Desensitizing in the Bloodstream
-
Abstract Number: OC 74.4
Platelets Preferentially Bind Senescent Red Blood Cells and Regulate in their Clearance
-
Abstract Number: PB0747
Platelets Promoted Malignancy Involving Exosomal HMGB1
-
Abstract Number: PB0759
Platelets Show a Distinct Response in a Controlled Human Malaria Infection (CHMI) Model
-
Abstract Number: OC 58.4
Platelets Stimulate Programmed Death-ligand 1 Expression by Cancer Cells: Inhibition by Anti-platelet Drugs
-
Abstract Number: OC 61.1
Pleiotropic Role of miR-146a in Driving Metabolism Reprogramming Causes Platelet Hyperreactivity and Thrombosis
-
Abstract Number: OC 01.2
Podocyte Tissue Factor Suppresses Spontaneous Sterile Renal Inflammation
-
Abstract Number: OC 30.1
Podoplanin and Tissue Factor Cooperate in Triggering Microthrombosis in Experimental Glioblastoma and Are Released to Systemic Circulation as Cargo of Extracellular Vesicles
-
Abstract Number: PB0042
Polycationic Molecules Towards the Inhibition of Procoagulant and Antifibrinolytic Properties of Nucleic Acids
-
Abstract Number: PB1038
Ponatinib Induces Vasculitis with Immune Cells Expressing Coagulation Factors FV & FVIII
-
Abstract Number: PB0976
Ponatinib Inhibits Collagen Induced Platelet Aggregation and Coated-platelet Formation in Human Platelets
-
Abstract Number: PB0692
Population Parmacokinetics of rFXIII (Catridecacog) and Clinical Outcomes of Prophylaxis in an Italian Population of Patients with Factor XIII Deficiency
-
Abstract Number: PB0580
Population Pharmacokinetic Modeling of Factor Concentrates in Hemophilia: A Detailed, Clinical Overview and Evaluation of Best Practice
-
Abstract Number: LPB0059
Population Pharmacokinetics of Anti-Xa Levels in COVID-19 ICU Patients Receiving Prophylaxis for Thrombo-embolic Events Using Nadroparin
-
Abstract Number: OC 20.4
Portal Vein Thrombosis(PVT) in Neonates and Children: A Ten-year Prospective Registry of a Tertiary Care Single-centre in Argentina
-
Abstract Number: PB0185
Post Hospital Discharge Thrombosis in Patients with COVID-19
-
Abstract Number: PB0527
Postoperative Bleeding Complications in Patients with Hemophilia Undergoing Major Orthopedic Surgery: A Prospective, Multicenter Observational Study
-
Abstract Number: OC 62.4
Postpartum Hemorrhage in Women with von Willebrand Disease and Carriers of Hemophilia: A Retrospective Analysis
-
Abstract Number: PB0587
Posttraumatic Stress Disorder and Posttraumatic Stress Symptoms Among Adults with Hemophilia A and B
-
Abstract Number: PB0251
Potential Markers to Predict Mortality in COVID-19
-
Abstract Number: LPB0021
Practical Application of FIX-Padua Field Study Results Enables a Comparison of FIX:C Results Across AAV Gene Therapy Trials Independent of FIX:C Assay Reported
-
Abstract Number: PB1281
Practical Considerations for Treatment of Left Ventricular Thrombus with Direct-acting Oral Anticoagulants
-
Abstract Number: LPB0056
Pre-admission Anticoagulant Therapy and Mortality in Hospitalized COVID-19 Patients: A Covid Predict Retrospective Cohort Study
-
Abstract Number: PB0559
Predicted FVIII Consumption of BAY 94-9027 Compared with Standard- and Extended-half-Life FVIII Products in Patients with Severe Hemophilia A
-
Abstract Number: PB0470
Predicting the Duration of Recombinant Factor VIIa Effect on Tail Bleeding by the Thrombin Generation Assay in Hemophilia A Mice
-
Abstract Number: OC 57.3
Prediction of Mortality in Patients with Recently Diagnosed Venous Thromboembolism: The GARFIELD-VTE Mortality Risk Model
-
Abstract Number: PB1125
Prediction of Venous Thromboembolism among Ambulatory Cancer Patients with Gastrointestinal Malignancies – A Retrospective Analysis
-
Abstract Number: PB1186
Predictors for Prognosis in Patients with Nonfatal Pulmonary Embolism in COVID-19 Pandemic
-
Abstract Number: OC 44.2
Predictors of Lupus Anticoagulant Test Variability over Time and its Associations with Future Thrombotic Events: Results from the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
-
Abstract Number: PB1277
Predictors of Recurrence of Venous Thromboembolic Disease after Suspension of Anticoagulation
-
Abstract Number: LPB0091
Predictors of the Development of the Post-thrombotic Syndrome: A Sub-analysis of the ATTRACT Trial
-
Abstract Number: PB1300
Preeclampsia and Inflammatory Lipid Mediators: A Longitudinal Study
-
Abstract Number: PB0658
Preferences of People with Hemophilia A and B for Treatments Including Gene Therapies in the US: A Discrete Choice Experiment
-
Abstract Number: PB1298
Pregnancy and Heparin: Peripartum Management. Experience of Two Centers in Argentina
-
Abstract Number: OC 34.4
Pregnancy from in vitro Fertilization is Associated with Increase in Risk of Venous Thromboembolism when Compared to Normal Pregnancy: A Systematic Review and Meta-analysis
-
Abstract Number: PB0805
Preliminary Results of the Adventh-pediatric Registry in a Southeastern Brazilian City
-
Abstract Number: PB1194
Premature Mortality Burden Related to Pulmonary Embolism in Cuba
-
Abstract Number: OC 75.1
Prenatal Therapy with Placental Cells Transduced with an Engineered fVIII Transgene Results in Curative fVIII Plasma Levels for 3 Years after Birth, Without Immune- or Toxicity-related Adverse Events
-
Abstract Number: PB0096
Preoperative Hemorrhagic Risk Assessment: Knowledge, Attitude and Practice among Surgeons and Anesthesiologists
-
Abstract Number: LPB0107
Preoperative Measurement of Platelet Contribution to Clot Stiffness (PCS) with the Quantra® QPlus® System and Bleeding after Cardiac Surgery
-
Abstract Number: PB1086
Prescribing Patterns, Efficacy and Safety of Direct Oral Anticoagulants (DOAC) Usage in a Tertiary Hospital
-
Abstract Number: OC 65.4
Prescription Patterns and Impact of Anticoagulant Therapy in Patients with Atrial Fibrillation who Had Active Cancer
-
Abstract Number: PB0365
Presentation of the Patient with Low Peak Dabigatran Levels in Plasma Suggests the Importance of Quantitative Measurement of DOAC Drugs in Clinical Decision Making and Treatment
-
Abstract Number: PB0913
Prevailing c.2435delC and Other VWF Gene Defects in Russian Patients with von Willebrand Disease Type 3. Four New Pathogenic Variants Found
-
Abstract Number: PB1213
Prevalence and Incidence of Deep Vein Thrombosis in Medical Critically Ill Patients: A Prospective Analysis in a Single Tertiary Care Centre in Thailand
-
Abstract Number: PB0929
Prevalence and Predictors of Iron Deficiency Anemia in Women with von Willebrand Disease: An NIS Study
-
Abstract Number: PB0612
Prevalence of Hematuria in Patients with Hemophilia A and B and its Association with Comorbidities: Experience from a Brazilian Center
-
Abstract Number: PB0387
Prevalence of Hemolysis, Icterus and Lipemia in the Coagulation Laboratory: Database Analyses
-
Abstract Number: PB0498
Prevalence of Hypertension in Hemophilia Patients: A Systematic Review
-
Abstract Number: PB0831
Prevalence of Thrombotic Events and Risk Factors in Patients with Primary Immune Thrombocytopenia
-
Abstract Number: PB0811
Prevalence of Venous Thrombembolic Events in the Czech Pediatric Population – Epidemiological Study
-
Abstract Number: LPB0010
Prevalence of Venous Thromboembolism and Pulmonary Embolism among Patients Hospitalized with a COVID-19 Diagnosis in France
-
Abstract Number: PB0281
Prevalence, Clinical Profile and Bleeding Risk of Hospitalized COVID-19 Patients Receiving Anticoagulation: A Retrospective Cross-sectional Study
-
Abstract Number: PB1093
Prevalence, Treatment and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
-
Abstract Number: LB 01.1
Prevention Of Arterial And Venous Vascular Events In Symptomatic Peripheral Arterial Disease Patients After Lower Extremity Revascularization in the VOYAGER PAD trial: Dual Anticoagulant/Antiplatelet Regimen Vs Antiplatelet Therapy Alone
-
Abstract Number: OC 47.1
Prevention of Thrombocytopenia and Thrombosis in Heparin-induced Thrombocytopenia (HIT) Using Deglycosylated KKO: A Novel Therapeutic for HIT?
-
Abstract Number: PB0625
Primary Prophiliaxis was Associated with a Lower Risk of Joint Damage in Colombian Men Patients with Hemophilia A
-
Abstract Number: LPB0045
Principles of Care for Women and Girls with Inherited Bleeding Disorders
-
Abstract Number: PB0175
Prior Use of Therapeutic Anticoagulation Does Not Protect against COVID-19 Related Clinical Outcomes in Hospitalized Patients: A Propensity Score-matched Cohort Study
-
Abstract Number: PB1084
Procedural Success of Left Atrial Appendage Occlusion Device in Patients with Chronic Kidney Disease: Meta-analysis of Real-world Data
-
Abstract Number: PB0428
Producing if Tenecteplase with High Activity
-
Abstract Number: PB0313
Profiling of Inflammatory Biomarkers and Coagulation Factors in End-stage Renal Disease
-
Abstract Number: PB0236
Prognostic Coagulation Parameters in COVID-19 Patients at the ICU
-
Abstract Number: OC 73.3
Prognostic Impact of Acute Kidney Injury in Patients with Acute Pulmonary Embolism. Data from the RIETE Registry
-
Abstract Number: PB0012
Prognostic Significance of von Willebrand Factor in Flow-mediated Dilatation Test at Patients with Arterial Hypertension and Diabetes Type 2
-
Abstract Number: OC 44.3
Progression of Ischaemic and Haemorrhagic Brain Lesions on MRI in APS Patients on Antithrombotic Therapy
-
Abstract Number: PB0418
Prolonged Tourniquet Application in the Hind Limb of Rats Is Associated with Fibrinolysis
-
Abstract Number: PB0593
Promising Prospective Data on the Effect of Ankle Joint Distraction in Hemophilic Arthropathy: Three Year Follow-up
-
Abstract Number: PB0490
Properties of FVIII Concentrate Were Obtained by the Method of Dye-ligand Affinity Chromatography
-
Abstract Number: PB0288
Prophylactic Anticoagulation in Hospitalized Patients with COVID-19: A Survey of Practices in Latin America
-
Abstract Number: PB1312
Prophylactic Radiological Interventions to Reduce Postpartum Haemorrhage in Patients with Placenta Accreta Spectrum Disorders
-
Abstract Number: PB0919
Prophylactic Subcutaneous Emicizumab-kxwh in Adults and Children with Symptomatic Type 3 von Willebrand Disease
-
Abstract Number: OC 51.1
Prospective Cohort Study on the Use of Low Molecular Weight Heparin Calibrated Anti-Xa Assay to Estimate Levels of Direct Oral Xa Inhibitors in Ex-vivo Patient Samples
-
Abstract Number: PB1210
Prospective Cohort: A 10 Years Experience with Hospitalized Patients with Venous Thromboembolic Disease from a Single-center Institutional Registry, Argentina
-
Abstract Number: PB0599
Prospective, Non-interventional Study with a Cohort to Assess Real-world Effectiveness (RWE) and Safety of Emicizumab in Persons with Hemophilia A (PwHA) without Inhibitors in Spain, Hemolution Cohort
-
Abstract Number: PB0502
Prospective, Open-label, Multicentre Phase II Study (PeKaFIX) to Evaluate the Pharmacokinetic Parameters of a Plasma Derived Factor IX Concentrate and Build a Pharmacokinetic Bayesian Model
-
Abstract Number: PB0615
Prostate Surgery in Patients with Hemophilia: A Monocentric Real-life Experience
-
Abstract Number: OC 35.3
Protein Arginine Deiminase 4 Inactivates Tissue Factor Pathway Inhibitor by Post-translational Modification of Functional Arginine Residues
-
Abstract Number: OC 35.2
Protein S Coordinates the Synergistic Inhibition of Prothrombinase by Tfpiα and Activated Protein C
-
Abstract Number: PB0395
Protein S Gla Domain as Theranostic for Early Vascular Calcification
-
Abstract Number: PB0315
Proteome Analysis of Extracellular Vesicles from Patients with Myocardial Infarction and Relation to Heart Function: An Observational Study
-
Abstract Number: LPB0044
Prothrombotic Biomarkers during Controlled Ovarian Stimulation for Assisted Reproductive Techniques
-
Abstract Number: PB0988
Prototyping of Physiological Stenosis with 2-photon Lithography for Thrombosis Studies
-
Abstract Number: PB0760
PSGL-1 is Important for Platelet-monocyte Aggregate Formation and Monocyte Maturation in Lentiviral Infection
-
Abstract Number: OC 34.1
Pulmonary Embolism and Deep Vein Thrombosis – Incidence, Comorbidities and Temporary Provoking Factors – A Nationwide Registry Study of 298,172 Patients
-
Abstract Number: PB1178
Pulmonary Embolism Diagnosis: Let’s Practice what we Preach. A Quality Improvement Study to Increase Adherence to Evidence-based PE Diagnosis in the Emergency Department
-
Abstract Number: PB0265
Pulmonary Embolism in COVID-19-Patients: Diagnostic Accuracy of D-dimer
-
Abstract Number: PB1146
Pulmonary Embolism in the Onset of Hematogenous Thrombophilia
-
Abstract Number: PB0176
Pulmonary Thromboembolism (PTE) in Hospitalised Patients with COVID-19: A National Study of Patients Managed in Critical Care and Ward Environments
-
Abstract Number: OC 55.2
Purifying the Needle in the Haystack: A Novel Immunoproteomic Pipeline for the Characterization Anti-FVIII Antibodies in Hemophilia A Inhibitor Patients
ISTH 2021 Congress
July 17-21, 2021. Philadelphia, PA.